SOLARA ACTIVE PHARMA SCIENCE
|
|
BOM : 541540     NSE : SOLARA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : Average [>25% and <50%] |
May 27,2022 |
Price(EOD): ₹ 430.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 1,548.00 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SOLARA ACTIVE PHARMA SCIENCE | 4% | -37.7% | -77.4% |
SUN PHARMACEUTICAL INDUSTRIES | -1.9% | -0.2% | 29.4% |
DIVIS LABORATORIES | -9.8% | -22.2% | -15.5% |
DR REDDYS LABORATORIES | 2.8% | 7.7% | -17.4% |
CIPLA | -0.4% | -1.1% | 3.1% |
GLAND PHARMA | -2.5% | -7.7% | -13% |
PIRAMAL ENTERPRISES | -12.8% | -23.8% | 9.1% |
CADILA HEALTHCARE | 3.1% | 8.4% | -40.1% |
TORRENT PHARMACEUTICALS | 12.4% | 8.5% | 6.5% |
FUNDAMENTAL ANALYSIS OF SOLARA ACTIVE PHARMA SCIENCE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SOLARA ACTIVE PHARMA SCIENCE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
6.98
P/E Calculated based on EPS of 61.64
[ Mar2021 - Consolidated Results ] 0.97
P/B Calculated based on Book Value of 441.18
[ Mar2021 - Consolidated Results ] 1.22
P/S Calculated based on Revenues of 1268.34 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-30% 18% 31% |
SHARE PRICE MOMENTUM OF SOLARA ACTIVE PHARMA SCIENCE
SOLARA ACTIVE PHARMA SCIENCE vs SENSEX
DEBT OF SOLARA ACTIVE PHARMA SCIENCE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.38 0.71 0.63 0.57 |
0.38 0.72 0.63 0.58 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SOLARA ACTIVE PHARMA SCIENCE
Pledged Promoter Shares |
27.51 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SOLARA ACTIVE PHARMA SCIENCE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
259.6% 113.97% 77.84% 101.29% |
-18.77% -86.35% -154.75% -96.8% |
QtrlyTrend |
0 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
SOLARA ACTIVE PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 500 | -0.1% | -6.8% | 7.2% |
S&P BSE ALLCAP | -0.3% | -7.1% | 7.5% |
S&P BSE 400 MIDSMALLCAP | -1.3% | -9.3% | 7.2% |
S&P BSE MIDSMALLCAP | -1.5% | -10.1% | 7.1% |
S&P BSE HEALTHCARE | -2% | -8.1% | -8.7% |
S&P BSE SMALL CAP | -2.8% | -11.4% | 10% |
S&P BSE 250 SMALLCAP | -2.9% | -12.2% | 6% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -0.2% | -6.9% | 7% |
NIFTY500 MULTICAP 50:25:25 | -0.8% | -8.3% | 7.2% |
NIFTY MID SMALL400 | -1.5% | -9.7% | 7.3% |
NIFTY SMALLCAP250 | -3% | -12.7% | 6.4% |
You may also like the below Video Courses
FAQ about SOLARA ACTIVE PHARMA SCIENCE
Is SOLARA ACTIVE PHARMA SCIENCE good for long term investment?
As on May 27,2022, the Fundamentals of SOLARA ACTIVE PHARMA SCIENCE look Strong and hence it may be good for long term investment! See Financial Performance of SOLARA ACTIVE PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SOLARA ACTIVE PHARMA SCIENCE UnderValued or OverValued?
As on May 27,2022, SOLARA ACTIVE PHARMA SCIENCE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE ?
As on May 27,2022, the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE is Rs. 363.33 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 614.08
Fair Value [Median EV / Sales Model] : Rs. 363.33
Fair Value [Median Price / Sales Model] : Rs. 328.29
Median Fair Value of SOLARA ACTIVE PHARMA SCIENCE : Rs. 363.33
Is SOLARA ACTIVE PHARMA SCIENCE trading at a Premium or Discount?
As on May 27,2022, SOLARA ACTIVE PHARMA SCIENCE is trading at a Premium of 18% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
